CD19 and neoplasm: By contrast, mice treated with IT-delivered CD19-BBz-CAR T cells experienced rapid tumor progression requiring euthanasia at approximately four weeks (Fig. 2b and c) (n = 20) and had evidence of tumor upon immunohistochemical examination of the brain post-mortem (Additional file 2: Figure S2A).